Product Image

Ginkgold 120 mg

Nature's Way
4.5
★ ★ ★ ★ ★
(2624 ratings)
Ginkgo
Product Image
Score83
A practical ginkgo serving for circulation-related cognitive use. The branded extract provides well-defined active markers and a controlled ginkgolic-acid specification, improving potency and purity confidence.
How scoring works
Quantity:150 Tablet(s) • (75 servings)
Goals:
Brain Health
Productivity Boost
Cognitive Support
Mental Focus
Vision Support

Score 83

A practical ginkgo serving for circulation-related cognitive use. The branded extract provides well-defined active markers and a controlled ginkgolic-acid specification, improving potency and purity confidence.
How scoring works
$32.45($0.43 per serving)
Vitacost
$ 37.07
Pure Formulas
$ 33.54
Vitacost
$ 37.07
iHerb
$ 32.45
Amazon
$ 33.71
iHerb
$ 33.05
Report prices

Analysis

The tablet serving provides 120 mg ginkgo extract, targeting cerebral and peripheral circulation. The amount fits common daily cognitive use.

Ginkgo may support selected memory, focus, or circulation-related outcomes, but it is not a broad nootropic. Its vision relevance is also narrow because it does not supply lutein, zeaxanthin, retinal omega-3 fats, or antioxidant minerals.

The branded extract provides well-defined active markers and a controlled ginkgolic-acid specification, improving potency and purity confidence. The focused format is easy to understand, though extract quality matters more than raw leaf weight or package size.

Who is it for
  • Adults seeking focused ginkgo supplementation
  • Users interested in circulation-related cognitive support
  • People who prefer a tablet serving
Best for
  • Targeted ginkgo use
  • Memory and focus routines in suitable adults
  • Users seeking a single-botanical formula

Pros

  • Ginkgo amount is clearly listed
  • Focused formula is easy to assess
  • Amount fits common daily use
  • Stimulant-free botanical

Cons

  • Does not provide broad cognitive pathway coverage
  • Not a complete vision formula
  • Benefits remain situation-dependent
  • No complementary nutrients are included

Warnings

  • Ginkgo may add to warfarin, direct oral anticoagulants, aspirin, or other antiplatelet effects and increase bleeding risk
  • Stop ginkgo before surgery or an invasive procedure when directed by the treating clinician because of its bleeding effects
  • Ginkgo may cause headache, dizziness, or digestive upset in sensitive users

Nutrient quality

93 Highest impact

A standardized branded extract and meaningful amount provide strong ingredient quality. Minor tablet bulk does not materially weaken the focused design.

.

Ingredient transparency

84 Highest impact

The branded extract and active amount are clearly disclosed without a hidden blend. Daily-use directions and non-active tablet ingredients are not supplied.

.

Customer satisfaction

65 Moderate impact

The available rating is favorable and the sample is large. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

87 Highest impact

The standardized extract and substantial supply justify the premium well. Strong quality assurance supports competitive effective-serving value.

.
Report analysis

Goals

Brain Health
Impact
Highest effect
B Goal FitA+ Strength of SupportC- CoverageA+ Formula Quality

A standardized branded ginkgo extract provides targeted support for cerebral circulation and may aid cognition in suitable users. Evidence is more relevant to older adults or impaired circulation than to healthy young adults.

The 120 mg amount and active-marker profile are clearly aligned with established extracts. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Highest effect
B Goal FitA Strength of SupportC- CoverageA+ Formula Quality

Standardized Ginkgo extract may support mental clarity and circulation at a clinically aligned amount. Its evidence is stronger for age-related cognitive concerns than for immediate productivity in healthy adults.

The branded extract provides unusually strong marker and purity disclosure. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Cognitive Support
Impact
Highest effect
B+ Goal FitA- Strength of SupportC- CoverageA Formula Quality

Branded ginkgo extract is well aligned with cerebral circulation, attention, and memory support, particularly in older adults with cognitive decline. The extract amount matches common studied use, though the label does not give the percentages of its flavone glycosides and terpene lactones.

The single botanical does not support brain membranes, neurotransmitter building blocks, or stress adaptation, and benefits in healthy young users are less reliable. Ginkgo may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Mental Focus
Impact
High effect
C Goal FitA Strength of SupportC- CoverageA+ Formula Quality

Standardized ginkgo may support cerebral circulation, processing speed, and attention, with the clearest relevance in older adults. Human findings for focus in healthy people are mixed, so it is less dependable than established acute nootropics.

The 120 mg amount reaches a commonly used starting dose, and flavone glycosides plus terpene lactones are identified. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, especially around surgery.

Study evidence
Ginkgo Supportive 28 studies
Vision Support
Impact
High effect
C- Goal FitA Strength of SupportD+ CoverageA Formula Quality

Ginkgo may support ocular microcirculation and eye-strain comfort, but evidence for long-term retinal protection is limited. It does not provide the carotenoids, omega-3 fats, or core antioxidant nutrients used in established eye formulas.

The a branded standardized extract improves quality confidence, while the meaningful amount fits commonly used supplemental dosing. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Total Carbohydrate
1 Gram(s)
Ginkgold Ginkgo biloba extract (Ginkgo Flavone Glycosides, Terpene Lactones)
120 mg
Gluten Free Adults 18–50 Vegan Dairy Free Women Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

A well-standardized branded extract provides a clinically relevant daily amount with strong purity assurance. The clearly disclosed dose makes the formula easy to assess, while the known low-ginkgolic-acid specification supports safer routine use. Its cost per useful amount is favorable despite the premium extract.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health Cognitive Support forGinkgo
  2. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  4. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  5. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  6. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  12. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  13. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  14. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  20. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  21. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  22. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  23. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  24. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  25. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  26. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  27. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo